Back to Report Store Home

Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth

  • Published: May-2013
  • Report Code: GBIHC276MR
  • Report Format: pdf

Description

List of Tables

Table 1: Travel Vaccines Market, Top Seven Markets, Vaccine-Preventable Diseases, 2012

Table 2: Travel Vaccines Market, Top Seven Markets, Traveler Population (million), 2007–2012

Table 3: Travel Vaccines Market, Top Seven Markets, Traveler Population Forecast (million), 2012–2019

Table 4: Travel Vaccines Market, US, Hepatitis A Vaccines, Revenue ($m), 2007–2012

Table 5: Travel Vaccines Market, US, Hepatitis A Vaccines, Revenue Forecast ($m), 2012–2019

Table 6: Travel Vaccines Market, Top Five European Countries, Hepatitis A Vaccines, Revenue ($m), 2007–2012

Table 7: Travel Vaccines Market, Top Five European Countries, Hepatitis A Vaccines, Revenue Forecast ($m), 2012–2019

Table 8: Travel Vaccines Market, Japan, Hepatitis A Vaccines, Revenue ($m), 2007–2012

Table 9: Travel Vaccines Market, Japan, Hepatitis A Vaccines, Revenue Forecast ($m), 2012–2019

Table 10: Travel Vaccines Market, US, Hepatitis A Vaccines, Cost ($), 2007–2012

Table 11: Travel Vaccines Market, US, Hepatitis A Vaccines, Cost ($), 2012–2019

Table 12: Travel Vaccines Market, Top Five European Countries, Hepatitis A Vaccines, Cost ($), 2007–2012

Table 13: Travel Vaccines Market, Top Five European Countries, Hepatitis A Vaccines, Cost Forecast ($), 2012–2019

Table 14: Travel Vaccines Market, Japan, Hepatitis A Vaccines, Cost ($), 2007–2012

Table 15: Travel Vaccines Market, Japan, Hepatitis A Vaccines, Cost Forecast ($), 2012–2019

Table 16: Travel Vaccines Market, Global, Hepatitis A Vaccines, Phase III (Inactive) Pipeline, 2012

Table 17: Travel Vaccines Market, Global, Hepatitis A Vaccines, Preclinical and Discovery (Inactive) Pipeline, 2012

Table 18: Travel Vaccines Market, US, Hepatitis B Vaccines, Revenue ($m), 2007–2012

Table 19: Travel Vaccines Market, US, Hepatitis B Vaccines, Revenue Forecast ($m), 2012–2019

Table 20: Travel Vaccines Market, Top Five European Countries, Hepatitis B Vaccines, Revenue ($m), 2007–2012

Table 21: Travel Vaccines Market, Top Five European Countries, Hepatitis B Vaccines, Revenue Forecast ($m), 2012–2019

Table 22: Travel Vaccines Market, Japan, Hepatitis B Vaccines, Revenue ($m), 2007–2012

Table 23: Travel Vaccines Market, Japan, Hepatitis B Vaccines, Revenue Forecast ($m), 2012–2019

Table 24: Travel Vaccines Market, US, Hepatitis B Vaccines, Cost ($), 2007–2012

Table 25: Travel Vaccines Market, US, Hepatitis B Vaccines, Cost Forecast ($), 2012–2019

Table 26: Travel Vaccines Market, Top Five European Countries, Hepatitis B Vaccines, Cost ($), 2007–2012

Table 27: Travel Vaccines Market, Top Five European Countries, Hepatitis B Vaccines, Cost ($), 2012–2019

Table 28: Travel Vaccines Market, Japan, Hepatitis B Vaccines, Cost ($), 2007–2012

Table 29: Travel Vaccines Market, Japan, Hepatitis B Vaccines, Cost Forecast ($), 2012–2019

Table 30: Travel Vaccines Market, Global, Hepatitis B Vaccines, Registration and Phase III Pipeline, 2012

Table 31: Travel Vaccines Market, Global, Hepatitis B Vaccines, Phase II Pipeline, 2012

Table 32: Travel Vaccines Market, Global, Hepatitis B Vaccines, Phase I Pipeline, 2012

Table 33: Travel Vaccines Market, Global, Hepatitis B Vaccines, Preclinical and Discovery Pipeline, 2012

Table 34: Travel Vaccines Market, US, Japanese Encephalitis Vaccines, Revenue ($m), 2007–2012

Table 35: Travel Vaccines Market, US, Japanese Encephalitis Vaccines, Revenue Forecast ($m), 2012–2019

Table 36: Travel Vaccines Market, Top Five European Countries, Japanese Encephalitis Vaccines, Revenue ($m), 2007–2012

Table 37: Travel Vaccines Market to 2019, Japanese Encephalitis Vaccines, Top Five European Countries, Revenue Forecast ($m), 2012–2019

Table 38: Travel Vaccines Market, Japan, Japanese Encephalitis Vaccines, Revenue ($m), 2007–2012

Table 39: Travel Vaccines Market, Japan, Japanese Encephalitis Vaccines, Revenue Forecast ($m), 2012–2019

Table 40: Travel Vaccines Market, US, Japanese Encephalitis Vaccines, Cost ($), 2007–2012

Table 41: Travel Vaccines Market, US, Japanese Encephalitis Vaccines, Cost Forecast ($), 2012–2019

Table 42: Travel Vaccines Market, Top Five European Countries, Japanese Encephalitis Vaccines, Cost ($), 2007–2012

Table 43: Travel Vaccines Market, Top Five European Countries, Japanese Encephalitis Vaccines, Cost Forecast ($), 2012–2019

Table 44: Travel Vaccines Market, Japan, Japanese Encephalitis Vaccines, Cost ($), 2007–2012

Table 45: Travel Vaccines Market, Japan, Japanese Encephalitis Vaccines, Cost Forecast ($), 2012–2019

Table 46: Travel Vaccines Market, Global, Japanese Encephalitis Vaccines, Registration, 2012

Table 47: Travel Vaccines Market, Global, Japanese Encephalitis Vaccines, Preclinical and Discovery, 2012

Table 48: Travel Vaccines Market, US, Meningococcal Vaccines, Revenue ($m), 2007–2012

Table 49: Travel Vaccines Market, US, Meningococcal Vaccines, Revenue Forecast ($m), 2012–2019

Table 50: Travel Vaccines Market, Top Five European Countries, Meningococcal Vaccines, Revenue ($m), 2007–2012

Table 51: Travel Vaccines Market, Top Five European Countries, Meningococcal Vaccines, Revenue Forecast ($m), 2012–2019

Table 52: Travel Vaccines Market, US, Meningococcal Vaccines, Cost ($), 2007–2012

Table 53: Travel Vaccines Market, US, Meningococcal Vaccines, Cost Forecast ($), 2012–2019

Table 54: Travel Vaccines Market, Top Five European Countries, Meningococcal Vaccines, Cost ($), 2007–2012

Table 55: Travel Vaccines Market, Top Five European Countries, Meningococcal Vaccines, Cost Forecast ($), 2012–2019

Table 56: Travel Vaccines Market, Global, Meningococcal Vaccines, Registration and Phase III Pipeline, 2012

Table 57: Travel Vaccines Market, Global, Meningococcal Vaccines, Phase II Pipeline, 2012

Table 58: Travel Vaccines Market, Global, Meningococcal Vaccines, Preclinical Pipeline, 2012

Table 59: Travel Vaccines Market, US, Rabies Vaccines, Revenue ($m), 2007–2012

Table 60: Travel Vaccines Market, US, Rabies Vaccines, Revenue Forecast ($m), 2012–2019

Table 61: Travel Vaccines Market, Top Five European Countries, Rabies Vaccines, Revenue ($m), 2007–2012

Table 62: Travel Vaccines Market, Top Five European Countries, Rabies Vaccines, Revenue Forecast ($m), 2012–2019

Table 63: Travel Vaccines Market, Japan, Rabies Vaccines, Revenue ($m), 2007–2012

Table 64: Travel Vaccines Market, Japan, Rabies Vaccines, Revenue Forecast ($m), 2012–2019

Table 65: Travel Vaccines Market, US, Rabies Vaccines, Cost ($), 2007–2012

Table 66: Travel Vaccines Market, US, Rabies Vaccines, Cost Forecast ($), 2012–2019

Table 67: Travel Vaccines Market, Top Five European Countries, Rabies Vaccines, Cost ($), 2007–2012

Table 68: Travel Vaccines Market, Top Five European Countries, Rabies Vaccines, Cost Forecast ($), 2012–2019

Table 69: Travel Vaccines Market, Japan, Rabies Vaccines, Cost ($), 2007–2012

Table 70: Travel Vaccines Market, Japan. Rabies Vaccines, Cost Forecast ($), 2012–2019

Table 71: Travel Vaccines Market, Global, Rabies Vaccines, Phase II Pipeline, 2012

Table 72: Travel Vaccines Market, Global, Rabies Vaccines, Phase I Pipeline, 2012

Table 73: Travel Vaccines Market, Global, Rabies Vaccines, Preclinical Pipeline, 2012

Table 74: Travel Vaccines Market, US, Typhoid Vaccines, Revenue ($m), 2007–2012

Table 75: Travel Vaccines Market, US, Typhoid Vaccines, Revenue Forecast ($m), 2012–2019

Table 76: Travel Vaccines Market, Top Five European Countries, Typhoid Vaccines, Revenue ($m), 2007–2012

Table 77: Travel Vaccines Market, Top Five European Countries, Typhoid Vaccines, Revenue Forecast ($m), 2012–2019

Table 78: Travel Vaccines Market, US, Typhoid Vaccines, Cost ($), 2007–2012

Table 79: Travel Vaccines Market, US, Typhoid Vaccines, Cost Forecast ($), 2012–2019

Table 80: Travel Vaccines Market, Top Five European Countries, Typhoid Vaccines, Cost ($), 2007–2012

Table 81: Travel Vaccines Market, Top Five European Countries, Typhoid Vaccines, Cost Forecast ($), 2012–2019

Table 82: Travel Vaccines Market, Global, Typhoid Vaccines, Phase II Pipeline, 2012

Table 83: Travel Vaccines Market, Global, Typhoid Vaccines, Preclinical Pipeline, 2012

Table 84: Travel Vaccines Market, US, Yellow Fever Vaccines, Revenue ($m), 2007–2012

Table 85: Travel Vaccines Market, US, Yellow Fever Vaccines, Revenue Forecast ($m), 2012–2019

Table 86: Travel Vaccines Market, Top Five European Countries, Yellow Fever Vaccines, Revenue ($m), 2007–2012

Table 87: Travel Vaccines Market, Top Five European Countries, Yellow Fever Vaccines, Revenue Forecast ($m), 2012–2019

Table 88: Travel Vaccines Market, Japan, Yellow Fever Vaccines, Revenue ($m), 2007–2012

Table 89: Travel Vaccines Market, Japan, Yellow Fever Vaccines, Revenue Forecast ($m), 2012–2019

Table 90: Travel Vaccines Market, US, Yellow Fever Vaccines, Cost ($), 2007–2012

Table 91: Travel Vaccines Market, US, Yellow Fever Vaccines, Cost Forecast ($), 2012–2019

Table 92: Travel Vaccines Market, Top Five European Countries, Yellow Fever Vaccines, Cost ($), 2007–2012

Table 93: Travel Vaccines Market, Top Five European Countries, Yellow Fever Vaccines, Cost Forecast ($), 2012–2019

Table 94: Travel Vaccines Market, Japan, Yellow Fever Vaccines, Cost ($), 2007–2012

Table 95: Travel Vaccines Market, Japan, Yellow Fever Vaccines, Cost Forecast ($), 2012–2019

Table 96: Travel Vaccines Market, Global, Yellow Fever Vaccines, Phase III, 2012

Table 97: Travel Vaccines Market, Global, Yellow Fever Vaccines, Phase I, 2012

Table 98: Travel Vaccines Market, Global, Yellow Fever Vaccines, Preclinical and Discovery, 2012

Table 99: Travel Vaccines Market, India, Immunization Schedule, 2012

Table 100: Travel Vaccines Market, India, Major Vaccine Brands by Indication, 2012

Table 101: Travel Vaccines Market, China, Policies, 2012

Table 102: Travel Vaccines Market, Australia, Designated Bacterial Vaccines and Circumstances in which Vaccines may be Provided, 2011

Table 103: Travel Vaccines Market, Australia, Designated Viral Vaccines and Circumstances in which Vaccines may be Provided, 2011

Table 104: Travel Vaccines Market, Australia, Designated Combined Bacterial and Viral Vaccines and Circumstances in which Vaccines may be Provided, 2011

Table 105: Travel Vaccines Market, Australia, Immunization Schedule, 2012

Table 106: Travel Vaccines Market, Emerging Markets, Pipeline by Phase, 2012

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3500
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$10500
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards